Finally, genomic alterations (amplification or deletion) and/or point mutations of several histone methyltransferses and demethylases are increasingly being identified in cancers through the use of high-density SNP arrays and deep sequencing technologies [8,10-13,69,70]. The gene discussed is MBD2; the disease is cancer.